Home » Topics » BioWorld

BioWorld
RSS

GENTA ANNOUNCES IPO

Nov. 26, 1991

FDA PANEL RECOMMENDS INTRON A

Nov. 26, 1991

ACTISITE APPROVED IN THREE EUROPEAN COUNTRIES

Nov. 26, 1991

ANALYST PREDICTS DECLINE IN BIOTECH STOCKS

Nov. 26, 1991

APPOINTMENTS AND ADVANCEMENTS

Nov. 25, 1991

GENSIA SUBSIDIARY GETS ANDA FOR ANTIBIOTIC

Nov. 25, 1991

GENZYME LICENSES AMYLASE SUBSTRATE

Nov. 25, 1991

COURT HEARS KODAK INJUNCTION MOTION

Nov. 25, 1991

BIOMERICA TRIALS OF DIABETES TEST KITS

Nov. 25, 1991

NON-PEPTIDE SUBSTANCE P INHIBITOR

Nov. 25, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...